According to Vision Research Reports, the global respiratory disorders treatment market size surpassed at US$ 73.11 Bn in 2021 and is projected to grow at a CAGR of 6.2% from 2022 to 2030.
The global respiratory disorders treatment market size is projected to reach US$ 125.63 billion by 2030, increase in incidence of respiratory disorders, surge in supportive care products to meet the rise in demand for treatment of respiratory disorders, entry of new players, and rise in access to healthcare are projected to drive the global respiratory disorders treatment market.
The anticipated launch of novel therapies in the global respiratory disorders treatment market such as FibroGen’s FG-3019 and Promedior’s PRM-151 for idiopathic pulmonary fibrosis (IPF) are anticipated to augment the global respiratory disorders treatment market. Increase in incorporation of premium priced therapies such as immune checkpoint inhibitor (ICI) immunotherapies into the lung cancer treatment algorithm, particularly in the first-line setting and cystic fibrosis transmembrane conductance regulator (CFTR) modulator in the cystic fibrosis (CF) market is expected to be one major drivers to the market.
North America dominated the global respiratory disorders treatment market in 2019 and the trend is anticipated to continue during the forecast period. Increase in adoption of combination drugs, availability of target therapies of all major companies in the region, introduction of new drugs such as combination drugs and cystic fibrosis transmembrane conductance regulator (CFTR) modulator, and increase in use of these drugs are projected to drive the market in North America. Asia Pacific is expected to be a highly lucrative market for respiratory disorders treatment during the forecast period. The market in the region is likely to expand at a higher CAGR from 2019 to 2027.
Lung Microbiome Deploys Individual Treatment Decisions and Disease Status
The concept of lung microbiome is acquiring popularity in the respiratory disorders treatment market. Since some of the microorganisms in lungs are uninvited gatecrashers, lung microbiome helps to provide information about the status of an individual’s disease status.
Lung microbiome is as unique as an individual’s fingerprint, thus resulting in guided individual treatment decisions that help improve patient quality of life. The novel technique also has the potential to guide companies in the respiratory disorders treatment market to develop new medicines. As such, modern laboratory techniques are being deployed to gain information about the quantity and specificity of bacteria present in the sputum samples of individuals.
Several factors such as different organisms moving into the airways as well as environmental factors determine the composition of the lung microbiome among individuals. Thus, the importance of ‘friendly’ gut bacteria is gaining widespread acceptance for respiratory disorders treatment. Healthcare providers in the market of respiratory disorders treatment can increase their efficacy in lung microbiome to identify the symptoms and perhaps decipher the slow progression of respiratory infections.
Demand for Equipment in Low-income Countries to Differentiate Asthma against Self-limiting Viral Infections
Asthma is one of the most common non-communicable disease among children, with a high prevalence worldwide. This is evident since asthma dictates the highest revenue among all diseases in the respiratory disorders treatment market, where the market estimated to progress at a healthy CAGR of ~6% during the forecast period. However, challenges concerning non-availability of equipment and medications for the treatment of asthma in low-resource settings pose as a barrier for market growth. Hence, companies in the respiratory disorders treatment market should increase their production capabilities to meet the demands of healthcare facilities in low-income countries.
Sufficient availability of equipment and necessary medications helps healthcare professionals to differentiate between common respiratory conditions such as pneumonia and asthma versus self-limiting viral infections. Apart from this, there is a growing awareness about non-pharmacological interventions that are underutilized, but can ease symptoms of patients requiring respiratory disorders treatment.
Rise in Prevalence of Respiratory Diseases and Increase in Awareness about Respiratory Disorders Treatment to Drive Market
Rise in prevalence of respiratory diseases across the globe is a major factor projected to boost the growth of the global respiratory disorders treatment market. The geriatric and pediatric populations are highly susceptible to respiratory diseases due to genetics or some environmental factors including microbial exposure, exposure to passive smoking, and air pollution. This in turn increases the need of respiratory disorder treatment. According to the World Health Organization, presently, 235 million people are suffering from asthma across the globe and 338,000 deaths due to asthma were reported in 2015.
According to the Centers for Disease Control and Prevention (CDC) analysis data, prevalence of asthma was 7.8% in 2015, which increased to 7.9% in 2017 in North America alone. Asthma is one of the common lifelong chronic diseases. However, people are increasingly becoming aware about asthma and its treatment. This fuels the growth of the global respiratory disorders treatment market. The World Asthma Day is an annual event organized by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world. The month of May is considered as National Asthma and Allergy Awareness Month to control asthma and educate people to raise awareness and improve the lives of all people.
Combination Drugs to Dominate Market
In terms of drug class, the global respiratory disorders treatment market has been divided into bronchodilators, corticosteroids, combination drugs, antibiotics, target therapy, immunotherapy, CFTR, and others. The combination drugs segment dominated the global respiratory disorders treatment market in 2019 and the trend is likely to continue during the forecast period. This can be attributed to continuous innovation in long-term therapy such as combination therapy, which provides comfort to patients and prevents symptoms.
Nasal to be Preferable Route of Administration
Based on route of administration, the global respiratory disorders treatment market has been classified into nasal, oral, and injectable. The nasal segment dominated the global respiratory disorders treatment market in 2019. It is projected to be a lucrative segment of the global respiratory disorders treatment market during the forecast period. The growth of the nasal segment is due to nasal drug therapy for respiratory disorder treatment is the preferred route of administration and medication is absorbed directly to epithelium of the lung.
Retail Pharmacies to be Key Distribution Channel
In terms of distribution channel, the global respiratory disorders treatment market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment dominated the global respiratory disorders treatment market in terms of revenue in 2019 and the trend is anticipated to continue during the forecast period. Increase in the number of respiratory therapeutics being dispensed through retail pharmacies and rise in the number of retail pharmacies in developing countries make these pharmacies a major channel of distribution.
North America to Dominate Global Market
Geographically, the global respiratory disorders treatment market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global respiratory disorders treatment market in 2019, followed by Europe. North America accounted for major share of the global respiratory disorders treatment market in 2019, owing to the introduction of new drugs such as Vertex’s cystic fibrosis transmembrane conductance regulator (CFTR) modulator and increase in use of these drugs, and high prevalence of respiratory diseases in countries such as the U.S. The respiratory disorders treatment market in Asia Pacific is likely to expand at a higher CAGR from 2019 to 2027. Significant growth of the respiratory disorders treatment market in the region can be attributed to high prevalence of asthma and COPD and increase in demand for respiratory therapeutics.
Market Segmentation
By Disease
By Drug Class
By Route of Administration
By Distribution Channel
By Region
The Respiratory disorders treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Respiratory disorders treatment market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Respiratory disorders treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory disorders treatment market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Respiratory disorders treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Respiratory disorders treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Respiratory disorders treatment by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Respiratory disorders treatment market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Respiratory disorders treatment market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Respiratory disorders treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Respiratory disorders treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Respiratory disorders treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Respiratory disorders treatment market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Respiratory disorders treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Respiratory disorders treatment market. These factors have benefited the growth of the global market for Respiratory disorders treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Respiratory disorders treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Respiratory disorders treatment are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers